The frequency of depressive status in patients with type 2 diabetes mellitus
Vol. 24 No. 4 (2019), ORIGINAL PAPERS
Vol. 24 No. 4 (2019)

The frequency of depressive status in patients with type 2 diabetes mellitus

ORIGINAL PAPERS
https://doi.org/10.31793/1680-1466.2019.24-4.318
Published December 20, 2019
М.V. Shevchuk
Національна медична академія післядипломної освіти імені П.Л. Шупика, Київ, Україна
O.О. Tsiganenko
Київська міська клінічна лікарня № 6, Київ, Україна
O.V. Taranenko
ТМО «Психіатрія», Київ, Україна
V.V. Kryzhevsky
Київська міська клінічна лікарня № 6, Київ, Україна
B.M. Mankovsky
Національна медична академія післядипломної освіти імені П.Л. Шупика, Київ, Україна
pdf (Українська)

Keywords

diabetes mellitus, depressive episode, scale of depression, antidepressants, anxiolitics, psychotherapy.

How to Cite

ShevchukМ., Tsiganenko, O., Taranenko, O., Kryzhevsky, V., & Mankovsky, B. (2019). The frequency of depressive status in patients with type 2 diabetes mellitus. Endokrynologia, 24(4), 318-322. https://doi.org/10.31793/1680-1466.2019.24-4.318
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Mental disorders are one of the numerous complications in patients with diabetes mellitus (DM), which greatly enhances its course. This article presents the data of the conducted international research and the results obtained among patients in Ukraine. Aim — to research the frequency of depressive status in patients with type 2 DM. Material and methods. A total of 190 male and female patients were randomly assigned to conduct this observation, in accordance with the protocol of international study International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) protocol. As diagnostic materials were used adapted scale PHQ‑9, PAID, WHO, MINI‑6, Hamilton scale; measuring HbA1с level, lipid profile; processed data from medical history for the last
15 years, collection of anamnesis, general review; Advisory opinion of a psychiatrist, endocrinologist, surgeon of diabetic foot cabinet. Guided by the results of the decision on the appropriateness of treatment tactics with the use of sedative, antidepressants, anxiolitics, and the involvement of psychotherapy sessions. Results. The total number of randomized patients in the study was 190 (39.47% male) with an average duration of DM 2 type 9.3±1.2 years. Depressive
disorders were diagnosed in 10.7% of patients and interpreted by the results on the PHQ‑9 scale; 12.10% had moderate, moderately severe and severe depressive symptoms (PHQ>9). Such patients were recommended to conduct sessions of psychotherapy, the appointment of medication with antidepressants and targeted surveillance by a psychiatrist for the next year. Conclusion. The obtained results of this observation demonstrate the frequency of occurrence
of depressive disorders in patients with DM.

https://doi.org/10.31793/1680-1466.2019.24-4.318
pdf (Українська)

References

1. Angold A, Costello EJ, Worthman CM. Puberty and depression: the role of age, pubertal status or pubertal timing. Psychol Med. 1998;28:51-61.
2. Shikhman AR, Brinson DC, Valbracht J, Lotz MK. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol. 2001 Dec; 67(12):7001-8.
3. Coleman SM, Katon W. Treatment implications for comorbid diabetes mellitus and depression. Psychiatric Times. 2013 Jan; 30(1).
4. Introduction: Standards of Medical Care in Diabetes — 2018. Diabetes Care. 2018; 41 (Suppl 1):1-2.
5. Zheng Y, Ley SH, Hu FB. Global Etiology and Epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98.
6. Lloyd CE, Sartorius N, Cimino LC, Alvarez A, Guinzbourg de Braude M, Rabbani G, et al. The INTERPRET-DD study of diabetes and depression: a protocol. Diabet Med. 2015 Jul;32(7):925-34.
7. Olsen J, Baker M, Freund T. Consensus document on European brain research. J Neurol Neurosurg Psy chiatry. 2016;77:213-6.
8. American Diabetes Association. Standards of Medical Care in Diabetes. 2017;142:27-51.
9. Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes. Diabetes Care. 2011; 34: 752-62.
10. Lustman PJ, Penckofer SM, Clouse RE. Recent advances in understanding depression in adults with diabetes. Curr Diab Rep. 2007;7(2):114-22.
11. Lin EH, Von Korff MV. Mental disorders among persons with diabetes — Results from the World Mental Health Surveys. Psychosom Res. 2008;65:571-80.
12. Дедов ИИ. Сахарный диабет — опаснейший вызов мировому сообществу. Вестник РАМН. 2012;1:7-13. (Dedov II. Diabetes mellitus — the most dangerous challenge to the world community. Vestnik RAMN. 2012;1:7-13).
13. Блейхер ВМ, Крук ИВ, Боков СН. Клиническая патопсихология. Руководство для врачей и клинических психологов. Санкт-Петербург, МОДЭК, МПСИ. 2009; 624 с. (Bleicher VM, Kruk IV, Bokov SN. Clinical pathopsychology. A guide for doctors and clinical psychologists. St. Petersburg, MODEK, MPSI. 2009; 624 p.).
14. Papathanasiou A, Koutsovasilius A, Shea S, Philalithis A, Papathanasiou S, Melidonis A, Lionis C. The Problem Areas in Diabetes (PAID) scale: psychometric evaluation survey in a Greek sample with type 2 diabetes. J Psychiatr Ment Health Nurs. 2014 May;21(4):345-53.
15. International Diabetes Federation, IDF Diabetes Atlas. 8th ed. Brussels: IDF, 2017.

Downloads

Download data is not yet available.